| Literature DB >> 23420151 |
Silvia Marinho Ferolla1, Teresa Cristina Abreu Ferrari, Maria Luíza Pereira Lima, Tâmara Oliveira Reis, Wilson Campos Tavares, Osvaldo Flávio Melo Couto, Paula Vieira Texeira Vidigal, Maria Arlene Fausto, Cláudia Alves Couto.
Abstract
OBJECTIVE: Recent evidence suggests that non-alcoholic fatty liver disease is associated with diet. Our aim was to investigate the dietary patterns of a Brazilian population with this condition and compare them with the recommended diet.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23420151 PMCID: PMC3552450 DOI: 10.6061/clinics/2013(01)oa03
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Demographic, anthropometric, and laboratory data of NAFLD patients.
| Age (years) | 54.4 (29.0; 81.0) | 56.6 (36.0; 70.0) | 53.7 (29.0; 72.0) | 0.23a |
| Weight (kg) | 80.4 (53.5; 130.8) | 87.2 (63.0; 96.4) | 78.4 (53.5; 107.5) | 0.008a |
| BMI (kg/m2) | 32.2 (23.4; 44.7) | 31.0 (34.3; 31.1) | 32.6 (24.4; 41.6) | 0.16a |
| Glucose (mg/dl) | 98.0 (64.0; 387.0) | 94.0 (77.0; 275.0) | 98.0 (64.0; 387.0) | 0.48 |
| Insulin (μU/ml) | 10.1 (2.0; 23.5) | 9.2 (2.0; 15.8) | 10.4 (3.9; 24.0) | 0.50a |
| HOMA | 1.9 (0.5; 6.3) | 1.7 (0.5; 3.7) | 2.0 (0.8; 6.3) | 0.60 |
| Total cholesterol (mg/dl) | 211.0 (120.0; 423.0) | 187.0 (139.0; 291.0) | 216.0 (120.0; 423.0) | 0.03 |
| Triglycerides (mg/dl) | 173.0 (61.0; 620.0) | 156.0 (61.0; 618.0) | 178.0 (75.0; 620.0) | 0.60 |
| AST (x RV) | 0.7 (0.3; 4.9) | 0.7 (0.5; 1.8) | 0.7 (0.3; 4.9) | 1.00 |
| ALT ( x RV) | 0.6 (0.1; 3.3) | 0.6 (0.3; 2.4) | 0.6 (0.1; 3.3) | 0.50 |
| AP (x RV) | 0.8 (0.2; 2.7) | 0.7 (0.33; 1.1) | 0.8 (0.2; 2.7) | 0.30 |
| GGT (x RV) | 1.1 (0.3; 15.5) | 1.0 (0.4; 7.8) | 1.1 (0.3; 15.5) | 0.51 |
| Albumin (g/dl) | 4.4 (3.7; 5.2) | 4.5 (3.9; 5.0) | 4.4 (3.7; 5.2) | 0.61a |
NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; HOMA, homeostasis model assessment; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP, alkaline phosphatase; GGT, gamma-glutamyltransferase; RV, reference value. Means were compared using the t-test (a), and medians were compared using the Mann-Whitney test.
Clinical characteristics of NAFLD patients.
| Glucose intolerance or diabetes | 43.8 | 36.4 | 46.0 | 0.43 |
| HOMA ≥3 (without diabetes) | 22.5 | 20.0 | 23.0 | 1.00a |
| Insulin resistance | 62.3 | 55.6 | 64.1 | 0.51 |
| Hypercholesterolemia | 60.4 | 45.5 | 64.9 | 0.10 |
| Low HDL | 69.6 | 52.4 | 75.7 | 0.05 |
| Hypertriglyceridemia | 63.2 | 57.1 | 64.9 | 0.52 |
| Hypertension | 70.8 | 63.6 | 73.0 | 0.40 |
| Hyperuricemia | 11.7 | 19.1 | 9.6 | 0.26a |
| Hypothyroidism | 11.8 | 9.5 | 12.5 | 1.00a |
| Metabolic syndrome | 69.5 | 52.3 | 74.3 | 0.05 |
NAFLD, non-alcoholic fatty liver disease. Proportions were compared using the chi-square test or Fisher's exact test (a).
Distribution of NAFLD patients by category of adequacy / inadequacy of energy, macronutrient and fiber intake.
| Parameters | 24-hour food recall | Food frequency questionnaire | ||||||||
| Recommendation | Intake Amount | Adequate | Lower | Over | Intake Amount | Adequate | Lower | Over | ||
| Male | Female | Median/ Mean (range) | (%) | (%) | (%) | Median/ Mean (range) | ||||
| Energy | EER | EER | 2084.8 (1116.2; 4212.1) | 0.0 | 48.9 | 51.1 | 2507.9 (473.9; 6575.3) | 0.0 | 32.1 | 67.9 |
| Carbohydratea | 50-60% TEI | 270.5 (101.9; 485.7) | 28.7 | 53.2 | 18.1 | 320.3 (49.0; 1150.2) | 38.1 | 34.5 | 27.4 | |
| Protein | 0.8-1.0 g/kg | 75.4 (5.7; 178.2) | 22.3 | 34.0 | 43.7 | 73.5 (21.3; 238.8) | 22.6 | 32.1 | 45.2 | |
| Total fat | 25-35% TEI | 82.9 (32.4; 178.5) | 36.2 | 5.3 | 58.5 | 85.1 (17.7; 203.7) | 44.1 | 14.3 | 41.7 | |
| Saturated fat | <10% TEI | 22.8 (7.6; 82.2) | 0.0 | 38.3 | 61.7 | 20.9 (4.5; 64.5) | 0.0 | 33.3 | 66.7 | |
| MUFAa | <20% TEI | 23.2 (7.3; 45.4) | 0.0 | 100.0 | 0.0 | 24.1 (6.2; 73.2) | 0.0 | 100.0 | 0.0 | |
| PUFAa | <10% TEI | 24.1 (1.8; 50.5) | 0.0 | 52.1 | 47.9 | 25.8 (4.2; 81.5) | 0.0 | 54.8 | 45.3 | |
| Fiber | 20-30 g | 18.2 (6.3; 56.5) | 2.1 | 76.6 | 21.3 | 24.3 (8.0; 76.3) | 0.0 | 53.6 | 46.4 | |
NAFLD, non-alcoholic fatty liver disease; EER, energy expenditure requirements; TEI, total energy intake; MUFA, monounsaturated fat; PUFA, polyunsaturated fat. Mean (a).
Distribution of NAFLD individuals by category of adequacy / inadequacy of mineral and vitamin intake.
| Parameters | Recommendations | 24-hour food recall | Food frequency questionnaire | |||||||
| Intake Amount | Adequate | Lower | Over | Intake Amount | Adequate | Lower | Over | |||
| Male | Female | Mean/Median (range) | (%) | (%) | (%) | Mean/Median (range) | (%) | (%) | (%) | |
| Magnesium (mg)a | ≤30 yr: 330 >30 yr: 350 | ≤30 yr: 255 >30 yr: 265 | 183.8 (74.3; 534.3) | 0.0 | 86.2 | 13.8 | 349.7 (95.4; 2696.3) | 0.0 | 34.5 | 65.5 |
| Manganese (mg) | 2.3 | 1.8 | 1.6 (0.2; 13.8) | 0.0 | 68.1 | 31.9 | 2.4 (0.6; 9.6) | 0.0 | 32.1 | 67.9 |
| Phosphorus (mg) | 34 | 858.1 (178.5;1995.3) | 0.0 | 0.0 | 100.0 | 1003.6 (294.6;2791.2) | 0.0 | 0.0 | 100.0 | |
| Iron (mg) | 6.0 | 19-50 yr: 8.1 >50 yr: 5.0 | 7.1 (2.4; 19.4) | 0.0 | 33.3 | 66.7 | 7.4 (2.9; 21.1) | 0.0 | 35.7 | 64.3 |
| Sodium (g)a | ≤50 yr: 1.5 51-70 yr: 1.3 >70 yr: 1.2 | 1.2 (0.0; 3.8) | 2.1 | 66.0 | 31.9 | 1.3 (0.2; 3.7) | 0.0 | 56.0 | 44.1 | |
| Potassium (g)a | 4.7 | 2.0 (0.9; 5.4) | 0.0 | 97.9 | 2.1 | 2.6 (1.0; 7.0) | 0.0 | 95.2 | 4.8 | |
| Copper (μg) | 700 | 654.1 (209; 3004.4) | 0.0 | 39.4 | 60.6 | 1257.2 (380.9; 5442.5) | 0.0 | 40.0 | 60.0 | |
| Zinc (mg) | 9.4 | 6.8 | 8.8 (1.4; 25.4) | 0.0 | 29.8 | 70.2 | 8.0 (2.4; 30.6) | 0.0 | 39.3 | 60.7 |
| Vitamin A (μg) | 625 | 500 | 125.0 (0.0; 1275.2) | 0.0 | 91.6 | 8.4 | 267.4 (1.4; 5337.5) | 0.0 | 38.5 | 61.5 |
| Thiamine (mg) | 1.0 | 0.9 | 0.7 (0.1; 2.6) | 0.0 | 68.1 | 31.9 | 1.1 (0.3; 4.0) | 0.0 | 38.1 | 61.9 |
| Riboflavin (mg) | 1.1 | 0.9 | 1.0 (0.0; 3.7) | 0.0 | 46.8 | 53.2 | 1.2 (0.2; 4.1) | 1.2 | 35.7 | 63.1 |
| Pyridoxine (mg) | ≤50 yr: 1.3 >50 yr: 1.7 | ≤50 yr: 1.3 >50 yr: 1.5 | 0.7 (0.1; 3.7) | 0.0 | 76.6 | 23.2 | 0.9 (0.1; 4.7) | 0.0 | 64.3 | 35.7 |
| Niacin (mg) | 12 | 11 | 14.7 (0.5; 37.7) | 0.0 | 31.9 | 68.1 | 14.0 (3.4; 57.9) | 0.0 | 34.5 | 65.4 |
| Calcium (mg)a | ≤50 yr: 1000 >50 yr: 1200 | 18.0 (0.0; 444.0) | 0.0 | 76.6 | 23.4 | 79.2 (2.5; 620.6) | 0.0 | 95.2 | 4.8 | |
| Vitamin C (mg) | 75 | 60 | 360.0 (13.8; 1213.3) | 0.0 | 100.0 | 0.0 | 472.0 (108.6; 1734.4) | 0.0 | 94.1 | 5.9 |
NAFLD, non-alcoholic fatty liver disease. Recommendations are expressed as the adequate intake (a) or as the estimated average intake.
Comparison between the number of meals consumed by NAFLD patients containing various food groups and the recommended numbers.
| Food groups | Recommendation per 1000 kcal | Median/Minimum (range) | |
| Cereals, roots and tubers | 0.3 meals/day | 2.1 (0.4; 4.4) | <0.00005a |
| Legumes (beans and other plant foods rich in protein) | 0.5 meals/day | 0.6 (0.0; 3.9) | 0.0 a |
| Vegetables | 1.5 meals/day | 1.6 (0.0; 12.4) | 0.01 |
| Fruits | 1.5 meals/day | 0.9 (0.0; 7.4) | <0.00005 |
| Milk and dairy products | 1.5 meals/day | 0.4 (0.0; 1.9) | <0.00005 |
| Meat and eggs | 0.5 meals/day | 0.6 (0.0; 2.1) | 0.003 |
| Fats | 0.5 meals/day | 2.4 (0.3; 5.5) | <0.00005a |
| Sugars | 0.5 meals/day | 1.0 (0.0; 4.5) | <0.00005 |
NAFLD, non-alcoholic fatty liver disease. Non-normally distributed variables were compared using the Wilcoxon test, and normally distributed variables were compared using the paired t-test (a).